Literature DB >> 28124652

Culture-directed topical antibiotic treatment for chronic rhinosinusitis.

Victoria S Lee1, Greg E Davis.   

Abstract

BACKGROUND: Topical antibiotics, delivered optimally as high-volume culture-directed sinus irrigations, are being increasingly used for recalcitrant chronic rhinosinusitis (CRS). Their impact on subjective and objective outcome measures, however, is still unclear.
OBJECTIVE: To assess if the use of topical antibiotics in recalcitrant CRS is associated with improved 20-Item Sino-Nasal Outcome Test and Lund-Kennedy endoscopic scores, and to determine the negative posttreatment culture "control" rate.
METHODS: Patients were included in the study if they met diagnostic criteria for CRS, received high-volume topical antibiotic sinus irrigations twice daily for 1 month, between December 2009 and May 2015, and had undergone endoscopic sinus surgery. The primary outcome was the 20-Item Sino-Nasal Outcome Test score. Secondary outcomes were the Lund-Kennedy endoscopic score and a negative posttreatment culture "control" rate. Paired t-tests were used to compare pre- and posttreatment scores. Patients with cystic fibrosis were analyzed separately.
RESULTS: Of the 58 patients included, 47% had nasal polyposis, 57% had asthma, 16% had aspirin sensitivity, and 55% had environmental allergies. The median Lund-Mackay computed tomography score was 11 (interquartile range, 6-16), and the median time to follow-up was 8 weeks (interquartile range, 6-10 weeks). The 20-Item Sino-Nasal Outcome Test scores improved from pre- to posttreatment period, although this was not significant mean 1.5 [confidence interval {CI} 1.3, 1.7] to mean 1.3 [CI 1.1, 1.6]; p = 0.16). Lund-Kennedy endoscopic scores, however, significantly improved from pre- to posttreatment (mean 4.9 [CI 4.3, 5.6] to mean 4.1 [CI 3.5, 4.7]; p = 0.05). Of the 47 patients with complete culture data, 72% had negative posttreatment culture results, defined as "controlled." Only one patient discontinued treatment, related to discomfort from irrigations.
CONCLUSION: In patients with recalcitrant CRS, the use of topical antibiotics trended toward improvement in symptom severity and significantly improved endoscopic appearance. Furthermore, 72% had negative posttreatment culture results, meaning microbiological "control." The results of this study support the use of high-volume culture-directed topical antibiotics, and, in the future, more rigorous prospective studies are warranted.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28124652      PMCID: PMC5108841          DOI: 10.2500/ajra.2016.30.4380

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  16 in total

Review 1.  Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidenced-based review with recommendations.

Authors:  Zachary M Soler; Samuel L Oyer; Robert C Kern; Brent A Senior; Stilianos E Kountakis; Bradley F Marple; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2012-06-26       Impact factor: 3.858

2.  Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations.

Authors:  C Arturo Solares; Pete S Batra; Geraldine S Hall; Martin J Citardi
Journal:  Am J Otolaryngol       Date:  2006 May-Jun       Impact factor: 1.808

3.  Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis. A controlled study.

Authors:  D A Sykes; R Wilson; K L Chan; I S Mackay; P J Cole
Journal:  Lancet       Date:  1986-08-16       Impact factor: 79.321

Review 4.  Topical anti-infective sinonasal irrigations: update and literature review.

Authors:  Jivianne T Lee; Alexander G Chiu
Journal:  Am J Rhinol Allergy       Date:  2014 Jan-Feb       Impact factor: 2.467

5.  Microbiological outcomes following mupirocin nasal washes for symptomatic, Staphylococcus aureus-positive chronic rhinosinusitis following endoscopic sinus surgery.

Authors:  Joshua Jervis-Bardy; Peter-John Wormald
Journal:  Int Forum Allergy Rhinol       Date:  2011-12-13       Impact factor: 3.858

6.  Clinical practice guideline: adult sinusitis.

Authors:  Richard M Rosenfeld; David Andes; Neil Bhattacharyya; Dickson Cheung; Steven Eisenberg; Theodore G Ganiats; Andrea Gelzer; Daniel Hamilos; Richard C Haydon; Patricia A Hudgins; Stacie Jones; Helene J Krouse; Lawrence H Lee; Martin C Mahoney; Bradley F Marple; Col John P Mitchell; Robert Nathan; Richard N Shiffman; Timothy L Smith; David L Witsell
Journal:  Otolaryngol Head Neck Surg       Date:  2007-09       Impact factor: 3.497

7.  Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study.

Authors:  W J M Videler; C M van Drunen; J B Reitsma; W J Fokkens
Journal:  Rhinology       Date:  2008-06       Impact factor: 3.681

8.  Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis.

Authors:  Brent Uren; Alkis Psaltis; Peter-John Wormald
Journal:  Laryngoscope       Date:  2008-09       Impact factor: 3.325

9.  A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis.

Authors:  Joshua Jervis-Bardy; Samuel Boase; Alkis Psaltis; Andrew Foreman; Peter-John Wormald
Journal:  Laryngoscope       Date:  2012-08-02       Impact factor: 3.325

Review 10.  Update on evidence-based reviews with recommendations in adult chronic rhinosinusitis.

Authors:  Richard R Orlandi; Timothy L Smith; Bradley F Marple; Richard J Harvey; Peter H Hwang; Robert C Kern; Todd T Kingdom; Amber Luong; Luke Rudmik; Brent A Senior; Elina Toskala; David W Kennedy
Journal:  Int Forum Allergy Rhinol       Date:  2014-05-29       Impact factor: 3.858

View more
  5 in total

1.  Paradigm shifts in the medical and surgical management of rhinologic and allergic disease.

Authors:  Jivianne T Lee
Journal:  Am J Rhinol Allergy       Date:  2016-11-01       Impact factor: 2.467

Review 2.  Update on Intranasal Medications in Rhinosinusitis.

Authors:  Kornkiat Snidvongs; Sanguansak Thanaviratananich
Journal:  Curr Allergy Asthma Rep       Date:  2017-07       Impact factor: 4.806

3.  Manuka honey sinus irrigation for the treatment of chronic rhinosinusitis: a randomized controlled trial.

Authors:  Victoria S Lee; Ian M Humphreys; Patricia L Purcell; Greg E Davis
Journal:  Int Forum Allergy Rhinol       Date:  2016-12-09       Impact factor: 3.858

Review 4.  Current Perspective on Nasal Delivery Systems for Chronic Rhinosinusitis.

Authors:  Junhu Tai; Kijeong Lee; Tae Hoon Kim
Journal:  Pharmaceutics       Date:  2021-02-10       Impact factor: 6.321

5.  Endoscopic outcomes in patients with AERD treated with topical antibiotics and intranasal corticosteroids.

Authors:  Jhon F Martinez-Paredes; Garret Choby; Michael Marino; Devyani Lal; Osarenoma Olomu; Razan Alfakir; Janalee K Stokken; Erin O'Brien; Angela M Donaldson
Journal:  Front Cell Infect Microbiol       Date:  2022-07-22       Impact factor: 6.073

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.